Intercept Pharma falls again as article strikes cautious tone

Intercept Pharmaceuticals (ICPT -22.3%) is trading sharply lower again today, and is now down some 43% from Friday's intraday high.

Perhaps helping to tip sentiment today is SA contributor Dr. Paul Nunzio DeSantis, whose article, while not necessarily bearish, strikes a cautious tone.

"Ultimately, OCA should receive FDA approval. However, my bearish tone stems from the likelihood that it will take significantly longer than investors currently anticipate and may not meet physician expectations of reversing or stopping fibrosis," DeSantis says.

Full article

From other sites
Comments (1)
  • awakeinwa
    , contributor
    Comments (693) | Send Message
    relative to what? as it stands, there are virtually no solutions for NASH. If this engenders measurable improvements, it is, for all intents and purpose, it is essentially the only game in town.
    14 Jan 2014, 02:49 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs